Nuwaysir is currently chair of the Alliance for Regenerative Medicine and vice chair of Invenra, an antibody platform company he co-founded in 2011. He previously served as CEO at BlueRock Therapeutics, a Bayer Pharmaceuticals subsidiary, and will continue to chair that company's board. Before his position at BlueRock, Nuwaysir was president and CEO of Cellular Dynamics International and a member of senior management at NimbleGen Systems.

Startup Ensoma launches with gene therapy vector platform
A new genomic medicine startup called Ensoma made its corporate debut this week, raising $70 million in financing and entering into a strategic collaboration...